XML 14 R4.htm IDEA: XBRL DOCUMENT v3.25.4
STATEMENTS OF CONSOLIDATED INCOME - USD ($)
shares in Thousands, $ in Millions
12 Months Ended
Dec. 31, 2025
Dec. 31, 2024
[1]
Dec. 31, 2023
[1]
Income Statement [Abstract]      
Net sales $ 3,373.0 $ 3,024.0 $ 3,087.0
Costs and expenses:      
Cost of products sold, excluding depreciation and amortization 2,930.6 2,666.6 2,728.2
Depreciation and amortization 122.5 116.4 108.6
Selling, general, administrative, research and development 129.2 120.8 122.7
Restructuring costs 1.9 7.6 5.0
Other operating charges, net 0.0 0.4 0.0
Total costs and expenses 3,184.2 2,911.8 2,964.5
Operating income 188.8 112.2 122.5
Other (expense) income:      
Interest expense (50.1) (43.7) (46.9)
Other income, net - Note 13 11.3 19.5 7.4
Income before income taxes 150.0 88.0 83.0
Income tax provision (37.5) (22.3) [2] (15.2) [2]
Net income [4] $ 112.5 [3] $ 65.7 $ 67.8
Net income per common share:      
Basic $ 6.96 $ 4.08 $ 4.25
Diluted $ 6.77 $ 4.02 $ 4.21
Weighted-average number of common shares outstanding (in thousands):      
Basic 16,169 16,069 15,991
Diluted 16,622 16,319 16,131
[1] Adjusted to reflect the retrospective change in inventory valuation methodology from LIFO to WAC. See Note 18 for further discussion.
[2] Adjusted to reflect the retrospective change in inventory valuation methodology from LIFO to WAC. See Note 18 for further discussion.
[3] Adjusted to reflect the retrospective change in inventory valuation methodology from LIFO to WAC. See Note 18 for further discussion.
[4] See Note 16 for supplemental disclosure of cash flow information.